iiinova — where your digital self keeps evolving

Benjamin Besse

@benjaminbessemd.bsky.social

Medical Oncologist - Lung cancer, thymic tumors & NUT carcinomas. Head of Clinical Research @GustaveRoussy, Head of Scientific Chairs Council @EORTC. Messages reflect my own opinion.

Posts Replies Media

Benjamin Besse @benjaminbessemd.bsky.social · 26/03/2025

Debate on L1 for EGFR mut NSCLC : ‘easy osi’ then escalate to CT-ami, or use doublet upfront? Lazertinib+amivantmab likely to extend OS by ~ 1 yr vs osimertinib, but without cross over to CT-ami. Intensify only if ctEGFR not cleared after 4w of osi? #ELCC25

191

Benjamin Besse @benjaminbessemd.bsky.social · 03/12/2024

What can a test that identifies all previous viral infections in patients with lung cancer reveal about immunotherapy efficacy? #LCSM bit.ly/4fNuDDw

bit.ly

Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer

Introduction Immune checkpoint blockers (ICBs) revolutionized the treatment of patients with advanced non-small cell lung cancer (NSCLC) but only a fraction of them obtain a response, and clinical ben...

130